Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
<p><strong>Aim</strong>. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).</p><p><strong>Material and methods</strong>. Economic evaluation was performed from a position of the health ca...
Main Author: | O. V. Shatalova |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/439 |
Similar Items
-
Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
by: V.Y. Bogachev, et al.
Published: (2017-12-01) -
MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01) -
Choosing an anticoagulant for a patient with venous thromboembolic complications
by: Yu. M. Stoyko, et al.
Published: (2016-06-01) -
ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01) -
Фармакоэпидемиологическая и клинико-экономическая оценка профилактики венозных тромбоэмболических осложнений (реальная практика назначений)
Published: (2018-06-01)